Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Qu Biologics

Qu Biologics
2007 FOUNDED
PRIVATE STATUS
51-60 EMPLOYEES
Angel LATEST DEAL TYPE
$48.8K LATEST DEAL AMOUNT
4 INVESTORS
Description

Developer of a site specific immunotherapy designed to restore the body's normal immune function to treat cancer and other immune-related diseases. The company's immunotherapy utilizes built-in knowledge to direct an activated innate immune response to specific organs or tissues to respond productively to any pathology that may be present at that body site and it contains components from a single inactivated microbial species that the immune system recognizes as a common cause of infection in a specific organ or tissue, enabling medical researchers to develop therapy that can activate and train human immune system to fight cancer and other diseases.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 4475 Wayburne Drive
  • Suite 305
  • Burnaby, British Columbia V5G 4X4
  • Canada

+1 (604) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Qu Biologics’s full profile, request a free trial.

Qu Biologics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Angel (individual) 04-Jun-2018 $48.8K 000.00 Completed Clinical Trials - Phase 2
7. Angel (individual) 12-Apr-2016 00.000 000.00 Completed Clinical Trials - Phase 2
6. Grant 06-Apr-2016 00000 000.00 Completed Clinical Trials - Phase 2
5. Angel (individual) 23-Dec-2015 00.000 000.00 Completed Generating Revenue
4. Angel (individual) 00.000 000.00 Completed Generating Revenue
3. Angel (individual) 17-Sep-2014 00.000 000.00 Completed Generating Revenue
2. Angel (individual) 01-Jun-2012 $4.86M $4.86M Completed Startup
1. Grant 25-May-2012 $3.07M Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Qu Biologics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Genome British Columbia Not-For-Profit Venture Capital 000 0000 000000 0
Julia Levy Angel (individual) Minority 000 0000 000000 0
National Research Council Canada Government 000 0000 000000 0
The Scientific Research and Experimental Development Government 000 0000 000000 0

Qu Biologics Executive Team (8)

Name Title Board
Seat
Contact
Info
Hal Gunn MD Chief Executive Officer, Board Member & Co-Founder
David Mullins Ph.D Chief Scientific Officer
Rob Freeman Co-Founder
Bob Cory Vice President, Business Development
Jim Pankovich Vice President, Clinical Operations & Drug Development

1 Former Executive

You’re viewing 5 of 8 executives. Get the full list »

Qu Biologics Board Members (5)

Name Representing Role Since Contact
Info
Hal Gunn MD Qu Biologics Chief Executive Officer, Board Member & Co-Founder 000 0000
Julia Levy Ph.D Self Board Member 000 0000
Michael Leschuk Qu Biologics Board Member 000 0000
Robert Pelzer Self Board Member 000 0000
Simon Sutcliffe MD Self Chief Medical Officer & Board Member 000 0000